Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2026)
Treace Medical Concepts (TMCI) posted Change in Account Payables of $6.8 million for Q1 2026, up 172.64% on a QoQ basis from -$9.4 million in Q4 2025, and up 152.17% year-over-year from $2.7 million in Q1 2025.
Treace Medical Concepts (TMCI) Change in Account Payables (2020 - 2026) Analysis & Trends
Treace Medical Concepts' Change in Account Payables history runs 7 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- Quarterly Change in Account Payables rose 152.17% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $314000.0 (up 103.96% YoY) and the FY2025 annual result came in at -$3.8 million, down 189.11% from the prior year.
- Change in Account Payables was $6.8 million for Q1 2026 at Treace Medical Concepts, up from -$9.4 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $9.3 million in Q1 2024 and bottomed at -$9.4 million in Q4 2025.
- A 5-year average of $557705.9 and a median of $576000.0 in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2022 — Change in Account Payables surged 1098.33% — and 2025, when it sank 769.44%.
- Treace Medical Concepts' Change in Account Payables stood at $787000.0 in 2022, then soared by 300.89% to $3.2 million in 2023, then plunged by 357.59% to -$8.1 million in 2024, then declined by 15.38% to -$9.4 million in 2025, then jumped by 172.64% to $6.8 million in 2026.
- Business Quant data shows TMCI's Change in Account Payables at $6.8 million in Q1 2026, -$9.4 million in Q4 2025, and -$3.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Treace Medical Concepts | 261.60 Mn | 209.75 Mn | 37.41 Mn | 6.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.81 Mn |
| Mar 31, 2026 | 6.81 Mn |
| Dec 31, 2025 | -9.38 Mn |
| Dec 31, 2025 | -9.38 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Sep 30, 2025 | -3.86 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Jun 30, 2025 | 6.74 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Mar 31, 2025 | 2.70 Mn |
| Dec 31, 2024 | -8.13 Mn |
| Dec 31, 2024 | -8.13 Mn |
| Sep 30, 2024 | 576,000.00 |
| Sep 30, 2024 | 576,000.00 |
| Jun 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -3.08 Mn |
| Mar 31, 2024 | 9.31 Mn |
| Mar 31, 2024 | 9.31 Mn |
| Dec 31, 2023 | 3.16 Mn |
| Dec 31, 2023 | 3.16 Mn |